Currently, inappropriate marketing such as stem cell therapy is attracting attention among researchers.Some treatments are not well understood for their efficacy and safety, and there is concern that excessive expectations may lead to great disappointment and distrust of stem cell research and treatment. There is.

The paper published this time collected and analyzed the website information of 2014 clinics that provide cell therapy for free medical care in Japan in May 5, before the introduction of the "Regenerative Medicine Safety Assurance Law *". thing.Many of the treatments have been offered as treatments for various diseases, including cancer, and as anti-aging for cosmetic purposes.Overall, while overemphasizing the benefits of treatment and the information presented in the media, there is little scientific explanation of the risks and meets the minimum criteria of the eHealth Ethics Code 24 *. I wasn't.

At present, medical information on websites is not subject to medical advertising regulations in Japan, and eHealth International Ethics Code 2.0 is still a self-regulation.Similar problems have been pointed out overseas, and it is expected that regulations in Japan will advance and that guidelines for disseminating medical information that will be unified internationally will be formulated in the future.

* Safety Assurance Law for Regenerative Medicine, etc.
The law that came into effect in November 2014 regarding ensuring the safety of technologies such as regenerative medicine and giving consideration to bioethics.

* EHealth Ethics Code 2.0
Voluntary standards for site operators to ensure quality and reliability from the user's point of view regarding medical / health information and services.A voluntary standard for site operators to strive to ensure quality and reliability from the standpoint of users.